Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LHX5 antisense RNA 1 (LHX5-AS1) is a long non-coding RNA (lncRNA) gene located on human chromosome 12, transcribed antisense relative to the LHX5 protein-coding gene[1][2][3][8]. Like other antisense lncRNAs, it does not encode a protein but may regulate the expression of the adjacent LHX5 gene, potentially through transcriptional interference or chromatin modification[4][7]. LHX5-AS1 is classified as an antisense RNA because it is transcribed from the opposite DNA strand relative to its sense (protein-coding) partner gene LHX5[1][3][7]. It is primarily identified by transcriptomic and genomic studies, and there is no direct experimental evidence linking LHX5-AS1 to a disease, validated biological function, or known drug interaction[5][6]. No evidence currently suggests LHX5-AS1 is a therapeutic target, biomarker, or associated with notable safety concerns, and its function remains largely uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LHX5 antisense RNA 1 (LHX5-AS1).